MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition

MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition

Bibliographic Details
Main Authors: Weitian Wei, Liang Wang, Liwei Xu, Jinxiao Liang, Lisong Teng
Format: Article
Language:English
Published: American Chemical Society 2021-11-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.1c02945

Internet

https://doi.org/10.1021/acsomega.1c02945

Similar Items